Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab, Methotrexate, and Cytarabine in PCNSL
NCT00517699Phase 2Terminated
- Sponsor
- Roche
- Start
- Sep 2007
- Primary completion
- Mar 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in primary central nervous system lymphoma (PCNSL), sponsored by Roche. Started Sep 2007; status: terminated.
02
Drugs
rituximab
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00517699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517699.